Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 193 is classified as a processed pseudogene derived from the 5S ribosomal RNA gene. Pseudogenes are non-functional genetic elements that arise from gene duplication or retrotransposition events. Unlike the functional 5S ribosomal RNA gene, which is a critical structural component of the large ribosomal subunit and participates in protein synthesis[3][5][7], RNA5SP193 does not produce a functional RNA product and has no known biological role. Pseudogenes may occasionally influence gene regulation by acting as decoys for miRNAs or through regulatory effects on their parental genes[8], but there is no documented evidence that RNA5SP193 exerts such effects. As a pseudogene, it is not considered a therapeutic target, does not interact with drugs, and is not associated with specific diseases or safety concerns[1][4][8]. In summary, RNA, 5S ribosomal pseudogene 193 (RNA5SP193) is a non-functional pseudogene and is not considered a drug target, receptor, enzyme, or relevant biomarker under current scientific nomenclature and knowledge.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 193 (RNA5SP193).